Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
3(27%)
Results Posted
43%(3 trials)

Phase Distribution

Ph phase_2
4
36%
Ph phase_1
1
9%
Ph phase_3
6
55%

Phase Distribution

1

Early Stage

4

Mid Stage

6

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
1(9.1%)
Phase 2Efficacy & side effects
4(36.4%)
Phase 3Large-scale testing
6(54.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

11

all time

Status Distribution
Active(3)
Completed(7)
Other(1)

Detailed Status

Completed7
Recruiting2
Active, not recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
3
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (9.1%)
Phase 24 (36.4%)
Phase 36 (54.5%)

Trials by Status

active_not_recruiting19%
completed764%
recruiting218%
unknown19%

Recent Activity

Clinical Trials (11)

Showing 11 of 11 trials
NCT07218796Phase 3

Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhone)

Recruiting
NCT07218783Phase 3

Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhine)

Recruiting
NCT06120842Phase 1

Evaluation of the Bimatoprost Implant System Used in Combination With the SpyGlass Intraocular Lens Compared to Timolol Ophthalmic Solution

Active Not Recruiting
NCT06152861Phase 2

Travoprost Ophthalmic Topical Cream for Open-angle Glaucoma or Ocular Hypertension

Unknown
NCT02754596Phase 2

Study Comparing Travoprost Intraocular Implants to Timolol Ophthalmic Solution

Completed
NCT03691649Phase 3

A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 3 Study

Completed
NCT01699464Phase 2

A Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months

Completed
NCT03691662Phase 3

A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 4 Study

Completed
NCT00465803Phase 3

A Phase IIIb Study of DuoTrav to Treat Glaucoma or Ocular Hypertension

Completed
NCT01302249Phase 2

AR-12286 in Combination With Latanoprost

Completed
NCT00293787Phase 3

A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

Completed

All 11 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
11